miRNA-195-5p通过准乳腺癌中的Wnt信号网络来调节细胞增殖和干细胞
Sanjeev Kumar1,2, Neeru Saini1,2
1CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi, 110007, India.
Non-coding RNA research
|October 6, 2025
概括
微RNA-195-5p有效抑制乳腺癌干细胞 (CSC) 的特性,通过降低关键干细胞标记物的调节和抑制Wnt/β-catenin信号传递. 这一发现揭示了miR-195-5p作为一种潜在的治疗药物来对抗癌症干和扩散.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤生长和抵抗.
- 针对CSC异质性和信号通路对于有效的癌症治疗至关重要.
- miR-195-5p在乳腺癌干细胞的作用需要进一步阐明.
研究的目的:
- 研究miR-195-5p在乳腺癌干细胞特性中的调控作用.
- 在CSC中识别由miR-195-5p调制的信号通路.
- 探索miR-195-5p在乳腺癌中的治疗潜力.
主要方法:
- 在MCF-7和MDA-MB-231乳腺癌细胞系中过度表达miR-195-5p.
- 使用免疫光和qPCR对茎状性标记物 (OCT4,SOX2,NANOG,CD44) 的分析.
- 露西法酶报告测试验证了Wnt/β-catenin通路组件 (GSK3β,FZD6) 的直接向.
- 功能性测试包括3D球体形成和扩散研究.
- 使用siRNA和小分子抑制剂扰乱Wnt信号传输.
主要成果:
- 在MCF-7细胞中,miR-195-5p过度表达显著降低了CSC干细胞标记物 (SOX2,CD44) 的调节.
- 在MCF-7和MDA-MB-231细胞系中观察到干性标志物表达 (SOX2,CD44) 的异质性.
- miR-195-5p直接针对GSK3β和FZD6,抑制了正规的Wnt/β-catenin信号传输.
- 在3D乳腺癌球体中,miR-195-5p的过度表达减少了扩散.
- 调节Wnt通路组件 (GSK3β,β-catenin) 影响了CSC的增殖和干性标记物.
结论:
- miR-195-5p作为一种强大的抑制乳腺癌干细胞特性.
- 这项研究通过Wnt/β-catenin信号抑制阐明了miR-195-5p的机制.
- miR-195-5p显示了针对乳腺癌干和扩散的显著治疗潜力.
相关概念视频
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Non-Canonical Wnt Signaling Pathways
8.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


